The risk of congestive heart failure: Sobering lessons from the Framingham heart study

Donald M. Lloyd-Jones*

*Corresponding author for this work

Research output: Contribution to journalReview article

65 Scopus citations

Abstract

This review highlights recent contributions of the Framingham Heart Study to our understanding of the epidemiology of congestive heart failure (CHF). Given its uniform criteria for the diagnosis of CHF and its long duration of follow-up, the Framingham study has had a unique perspective on the short- and long-term risk of developing CHF, its predisposing risk factors, and its prognosis in a general, communitybased population. Some recent studies from Framingham have provided important insights on CHF: the lifetime risk is estimated to be 20% for men and women; hypertension is the most important modifiable risk factor, with a population- attributable risk of CHF of 59% for women and 39% for men; a clinical prediction rule for development of CHF has recently been published; and the prognosis after development of CHF is grim, with a median survival of 1.7 years in men and 3.2 years in women.

Original languageEnglish (US)
Pages (from-to)184-190
Number of pages7
JournalCurrent Cardiology Reports
Volume3
Issue number3
DOIs
StatePublished - Dec 1 2001

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'The risk of congestive heart failure: Sobering lessons from the Framingham heart study'. Together they form a unique fingerprint.

  • Cite this